生物抗节律-通道 相互作用蛋白质
1Bronx, New York.
Transactions of the American Clinical and Climatological Association
|September 13, 2023
概括
电压通道 (NaV) 对于组织刺激至关重要,并与各种疾病有关. 纤维细胞生长因子 (FGFs) 结合到NaV 碳酸末端,通过抑制迟电流,提供潜在的抗失律疗法.
科学领域:
- 分子生物学分子生物学
- 神经科学是一个神经科学.
- 心脏病学 心脏病学
背景情况:
- 电压通道 (NaV) 对于细胞刺激至关重要.
- NaV通道的突变与各种人类疾病有关,包括和心律失常.
- NaV通道的炭结末是调节蛋白的关键相互作用点.
研究的目的:
- 研究卡尔莫杜林 (CaM) 和纤维细胞生长因子 (FGFs) 对NaV通道功能的调节作用.
- 探索FGFs作为向抗心律失常疗法的潜力.
主要方法:
- 研究了CaM和FGFs与NaV通道炭基末的相互作用.
- 研究了这些相互作用对NaV通道关口的影响,包括Ca2+依赖性无活化 (CDI) 和晚期Na电流 (Na-L).
- 利用FHF1A衍生的来评估其抗失律潜力.
主要成果:
- M结合调节了NaV关口,并调解了Ca2+-依赖的无活化.
- FGFs抑制CDI,并有力地抑制心律失常的晚期Na电流 (Na-L).
- 一个特定的FHF1A片段有效地抑制Na-L.
结论:
- 卡尔莫杜林和FGF是NaV通道功能的关键调节者.
- FGFs,特别是通过它们的氨基终端,抑制晚期Na电流.
- 一个短的FHF1A代表了一个有前途的抗心律失常剂.
相关概念视频
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.0K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.0K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
875
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
875
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
770
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
770
Mechanism of Cardiac Arrhythmias
950
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
950
Antihypertensive Drugs: Action of Calcium Channel Blockers
563
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
563


